Structural basis for the assembly and gate closure mechanisms of the Mycobacterium tuberculosis 20S proteasome.
Mycobacterium tuberculosis (Mtb) possesses a proteasome system analogous to the eukaryotic ubiquitin-proteasome pathway. Mtb requires the proteasome to resist killing by the host immune system. The detailed assembly process and the gating mechanism of Mtb proteasome have remained unknown. Using cryo-electron microscopy and X-ray crystallography, we have obtained structures of three Mtb proteasome assembly intermediates, showing conformational changes during assembly, and explaining why the beta-subunit propeptide inhibits rather than promotes assembly. Although the eukaryotic proteasome core particles close their protein substrate entrance gates with different amino terminal peptides of the seven alpha-subunits, it has been unknown how a prokaryotic proteasome might close the gate at the symmetry axis with seven identical peptides. We found in the new Mtb proteasome crystal structure that the gate is tightly sealed by the seven identical peptides taking on three distinct conformations. Our work provides the structural bases for assembly and gating mechanisms of the Mtb proteasome.
Li
Dongyang
D
Department of Biology, Brookhaven National Laboratory, Upton, NY, USA.
Li
Hua
H
Wang
Tao
T
Pan
Hong
H
Lin
Gang
G
Li
Huilin
H
D020285:Cryoelectron Microscopy; D018360:Crystallography, X-Ray; D008958:Models, Molecular; D009169:Mycobacterium tuberculosis / Q000737:chemistry* / Q000201:enzymology*; D046988:Proteasome Endopeptidase Complex / Q000737:chemistry* / Q000378:metabolism*; D011487:Protein Conformation; D055503:Protein Multimerization; D020836:Protein Structure, Quaternary
D046988:Proteasome Endopeptidase Complex
Structure. 2009 Oct 14;17(10):1377-85
19836337
Science. 2003 Dec 12;302(5652):1963-6
14671303
J Struct Biol. 1999 Dec 1;128(1):82-97
10600563
J Comput Chem. 2004 Oct;25(13):1605-12
15264254
Science. 1995 Apr 28;268(5210):533-9
7725097
Methods Enzymol. 1997;276:307-26
27754618
Nat Struct Biol. 1994 Nov;1(11):765-70
7634086
EMBO J. 1999 Jul 1;18(13):3575-85
10393174
J Mol Biol. 2004 Jan 2;335(1):233-45
14659753
J Biol Chem. 1997 Oct 17;272(42):26103-9
9334174
Cancer Treat Rev. 2003 May;29 Suppl 1:3-9
12738238
Nature. 2009 Oct 1;461(7264):621-6
19759536
Biochem Soc Trans. 2007 Feb;35(Pt 1):12-7
17212580
Mol Cell. 2005 May 27;18(5):589-99
15916965
Nat Struct Biol. 2000 Nov;7(11):1062-7
11062564
Nat Protoc. 2007;2(11):2728-33
18007608
Science. 1995 Apr 28;268(5210):579-82
7725107
Structure. 2006 Jul;14(7):1179-88
16843899
Curr Biol. 1995 Jul 1;5(7):766-74
7583123
J Mol Biol. 2003 Mar 7;326(5):1437-48
12595256
J Biol Chem. 2007 Jun 22;282(25):18448-18457
17430901
Mol Cell. 2009 May 14;34(4):473-84
19481527
Biophys J. 2004 Dec;87(6):4098-105
15361411
Mol Microbiol. 2005 Jan;55(2):561-71
15659170
Chem Rev. 2007 Mar;107(3):687-717
17316053
Annu Rev Biochem. 1999;68:1015-68
10872471
Structure. 2009 Aug 12;17(8):1137-47
19679091
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Mol Microbiol. 2006 Mar;59(5):1417-28
16468986
Mol Microbiol. 2006 Mar;59(5):1405-16
16468985
Trends Microbiol. 1999 Feb;7(2):88-92
10081087
Mol Cell. 2008 May 9;30(3):360-8
18471981
Nat Med. 2007 Dec;13(12):1515-20
18059281
J Struct Biol. 1996 Jan-Feb;116(1):190-9
8742743
J Biol Chem. 2008 Aug 22;283(34):23305-14
18534977
Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S25-33
18762150
FEBS Lett. 1997 Nov 24;418(1-2):189-94
9414124
EMBO J. 2010 Apr 7;29(7):1262-71
20203624
J Mol Biol. 2003 Mar 14;327(1):75-83
12614609
J Biol Chem. 2006 Apr 7;281(14):9569-75
16446364